摘要
随着外科技术的提高、术后免疫抑制剂的应用发展以及术后管理的完善，目前肺移植术后1年生存率已高达70％～80％，约有40％～50％的患者术后生存期超过5年。尽管术后的感染、药物的不良反应以及恶性肿瘤仍然是肺移植术后的主要并发症，但是真正限制肺移植患者长期生存的原因仍然是移植术后的慢性排异反应，即闭塞性细支气管炎。
出处
《中华结核和呼吸杂志》
CAS
CSCD
北大核心
2008年第3期220-222,共3页
Chinese Journal of Tuberculosis and Respiratory Diseases
参考文献19
-
1Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J, 2003,22:1007-1018.
-
2Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med,2002,166:440-444.
-
3Al-Githmi I, Batawil N, Shigemura N, et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg, 2006,30 : 846 -851.
-
4Glanville AR. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med, 2006, 27:480491.
-
5Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001 : an update of the diagnostic criteria. J Heart Lung Transplant, 2002,21:297-310.
-
6Nicod LP. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc, 2006,3:444-449.
-
7Schulman LL, Weinberg AD, McGregor CC, et al. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med, 2001,163:437-442.
-
8Sharples LD, McNeil K, Stewart S, et al. Risk factors for bronchiolitis obliterans : a systematic review of recent publications. J Heart Lung Transplant, 2002, 21:271-281.
-
9Lau CL, Palmer SM, Posther KE, et al. Influence of panelreactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg, 2000, 69 : 1520-1524.
-
10Hohlfeld J, Niedermeyer J, Harem H, et al. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant, 1996,15:888-894.
同被引文献12
-
1刘琳,岳淑英,李金丽,卢世臣.健康教育对首发精神分裂症病人自知力恢复、服药依从性及复发的影响[J].中华护理杂志,2004,39(5):330-332. 被引量：185
-
2Vos R, Vanaudenaerde B M, Verleden S E, et al. A ran- domised controlled trial of azithromycin to prevent chro- nic rejection after lung transplantation[J]. Eur Respir J, 2011,37(1) .,164-172.
-
3Suhling H, Rademacher J, Zinowsky I al. Conventional vs tablet computer-based patient education following lung transplantation- a randomized controlled trial[J]. PLoS One,2014,9(3) .. 1-8.
-
4Winsett R P, Arheart K, Stratta R J, et al. Evaluation of an immunosuppressant side effect instrument[J]. Prog Transplant, 2004,14(3) : 210-216,240.
-
5Bosma O H, Vermeulen K M, Verschuuren E A, et al. Adherence to immunosuppression in adult lung trans plant recipients: prevalence and risk factors[J]. J Heart Lung Transplant,2011,30(11) :1275-1280.
-
6Oliva M, Singh T P, Gauvreau K, et al. Impact of medi- cation non-adherence on survival after pediatric heart transplantation in the USA [J]. J Heart Lung Trans- plant,2013,32(9) :881-888.
-
7曹晓东,王世平,赵东方.肝移植受者服药依从性现状及其影响因素[J].中华护理杂志,2009,44(2):184-186. 被引量：28
-
8张弋,付鹏,张怡,沈中阳.50例器官移植患者免疫抑制剂的用药依从性调查[J].中国药师,2010,13(11):1646-1648. 被引量：8
-
9宋静,曹艳茹,姚景鹏.冠状动脉支架置入术后患者院外服药依从性的调查[J].中华现代护理杂志,2010,16(33):3983-3986. 被引量：6
-
10黄蓓蓓.住院精神病患者服药依从性的相关因素分析及护理对策[J].中国实用护理杂志,2011,27(25):53-54. 被引量：28
二级引证文献3
-
1金永梅,徐爱民,刘宏,韦韦,汪栋.2例濒危状态终末期肺病患者双肺移植围术期护理体会[J].东南国防医药,2016,18(4):419-421. 被引量：3
-
2徐海波,吴立平.1例allo-HSCT患者应用免疫抑制剂后出现失语的护理[J].中国继续医学教育,2016,8(30):255-256.
-
3游丽娟,钟超,雷芬,王晓芬,邓蕾,叶桂荣.器官移植患者术后服用免疫抑制剂依从性的 相关研究进展[J].实用器官移植电子杂志,2020,8(3):237-242. 被引量：4
-
1杨俊伟,黎磊石.移植肾的慢性排异反应[J].肾脏病与透析肾移植杂志,1994,3(5):423-428. 被引量：6
-
2罗永礼,张国良,白喜文,李扬兴,于立新,寿正哲.CsA治疗移植肾慢性排异反应24例报告[J].第一军医大学学报,1990,10(2):219-220.
-
3乔保平,赵明堂.肾移植慢性排异反应[J].国外医学（泌尿系统分册）,1990,10(3):117-120. 被引量：4
-
4段浩然.3例再次肾移植患者诊疗体会[J].河南外科学杂志,2004,10(5).
-
5杨瑞丽,蒋金根.肾移植后慢性排异反应合并大量心包积液1例[J].工企医刊,1996,9(3):112-112.
-
6杨丽敏,王守云,闫春伟,陈寒冬.肝移植后慢性排异反应1例[J].中国组织工程研究与临床康复,2011,15(5):823-826. 被引量：1
-
7胡先贵,金钢.胰腺癌手术策略的合理选择[J].上海医学,2010,33(11):983-985. 被引量：2
-
8周文勇,周晓慧,范慧敏.肺移植慢性排异反应动物模型研究进展[J].中国实验动物学报,2015,23(2):199-204.
-
9孟伟,李红艳.慢性移植肾肾病氧化应激增加[J].现代保健（医学创新研究）,2007(05X):49-50.
-
10张颖涛.内窥镜脂肪抽吸的临床应用发展[J].川北医学院学报,2003,18(4):169-171.
